Novartis

Ebitda Endring Dato
AbbVie USD 4.49B 2.26B 2024-03
Alcon AG USD 676M 84M 2024-03
Almirall EUR 18.5M 51.79M 2024-03
Amgen USD 2.16B 1.5B 2024-03
AstraZeneca USD 4.47B 1.67B 2024-03
Bayer EUR 4.35B 1.29B 2024-03
Biogen USD 681.5M 29.4M 2024-03
Bristol-Myers Squibb USD -8559000000 13.45B 2024-03
Eli Lilly USD 3.12B 720.2M 2024-03
Fresenius EUR 820M 427M 2024-03
Fresenius Medical Care EUR 774.12M 105.08M 2024-03
Galapagos EUR 23.19M 133.94M 2024-03
Genmab DKK 1.72B 16M 2024-03
Gilead Sciences USD -3542000000 6.27B 2024-03
GlaxoSmithKline GBP 2.07B 317M 2024-03
GRIFOLS EUR 334.62M 15.41M 2023-12
Hikma Pharmaceutical USD 504M 154M 2023-06
J&J USD 5.68B 776M 2024-03
Lonza CHF 922M 285M 2023-06
Merck EUR 1.43B 47M 2024-03
Merck USD 6.96B 557M 2024-03
Novartis USD 4.66B 20M 2024-03
Novartis USD 4.66B 20M 2024-03
Orion EUR 56M 37.6M 2024-03
Pfizer USD 5.95B 4.81B 2024-03
Philips EUR -800000000 1.71B 2024-03
Recordati EUR 221.86M 32.47M 2024-03
Regeneron Pharmaceuticals USD 830.9M 485.5M 2024-03
Roche Holding CHF 12.35B 1.92B 2023-06
Sanofi EUR 2.16B 1.86B 2024-03
UCB EUR 656M 205M 2023-06



Novartis - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.